none

Thesis (Ph. D.)--University of Washington, 2001. / Vita. Includes bibliographical references (leaves 64-69).

No description available.

No description available.

Objective : An audit of the use and outcomes of Radioactive Iodine (RAI) therapy in the definitive management of thyrotoxicosis at Inkosi Albert Luthuli Central Hospital (IALCH), KwaZulu-Natal, South Africa. Methods : The clinical records of all new patients with thyrotoxicosis, referred in a 4 year period between 01/01/2003 and 31/12/2006, were analysed. Response to RAI was monitored using biochemical parameters (namely, Thyroid Stimulating Hormone and Free T4 levels). Rates of euthyroidism (cure), hypothyroidism and hyperthyroidism (treatment failure) were correlated to dose of RAI. Patients were followed-up for at least 2 years or until the onset of hypothyroidism. The follow-up period was until 31/12/2007. Results : One hundred and fourteen patients (37.7%), of a cohort of 302 new thyrotoxic patients treated with RAI, met the inclusion criteria. Ninety-six patients (84.2%) had Graves Disease (GD) whilst 18 had Toxic Nodular Disease (TND). At 2 year follow-up, 91 patients (79.8%) were hypothyroid, 10 (8.8%) were euthyroid and 13 (11.4%) were hyperthyroid. The average dose of RAI to achieve euthyroidism was 10mCi and hypothyroidism, 9.7mCi. The average time to achieve euthyroidism was 5.9 months and 10.1 months to become hypothyroid. Thirty-one patients (27.2%) remained persistently hyperthyroid after one dose of RAI. Patients with GD (88.5%) were more likely to become hypothyroid (p < 0.001) whilst 38.9% of TND patients remained hyperthyroid (p = .001). Baseline TFT values were significant in terms of outcomes correlated with the prescribed RAI dose i.e Low Dose (<8mCi) vs. Intermediate Dose (8-9mCi) vs. High Dose (>9mCi)(TSH p = 0.05; FT4 p = 0.003; FT3 p = 0.001). Conclusion : The majority of patients became hypothyroid over time, in keeping with reported data. In the public health sector, where early access to RAI (in terms of waiting times for appointments for RAI) and follow-up are major problems, early cure is essential to minimize the morbidity of thyrotoxicosis and this may be achieved with an initial high dose of RAI. / Thesis (M.Med.)-University of KwaZulu-Natal, Durban, 2011.

No description available.

No description available.

Salt iodization is widely available throughout the developing world. Incorporating other micronutrients into the existing salt iodization process could prevent multiple deficiencies. The thesis objective was to develop a stable formulation of salt dual fortified with folic acid and iodine, using a single solution that could be sprayed on. The micronutrients needed to be fully solubilized and stable in solution for at least one month. In the absence of an alkaline environment or antioxidant, iodine losses occur most likely due to the oxidation of folic acid by potassium iodate. Optimal salt formulations were prepared by spraying a pH 9 carbonate-bicarbonate buffer solution containing folic acid and iodine dissolved at 0.35% (w/v) each. Acceptable micronutrient retentions of > 90% were observed in refined salt after 6 months of storage at 45°C/60% relative humidity. Further investigations into increasing the concentration of iodine and folic acid in the spray solution are recommended.

Salt iodization is widely available throughout the developing world. Incorporating other micronutrients into the existing salt iodization process could prevent multiple deficiencies. The thesis objective was to develop a stable formulation of salt dual fortified with folic acid and iodine, using a single solution that could be sprayed on. The micronutrients needed to be fully solubilized and stable in solution for at least one month. In the absence of an alkaline environment or antioxidant, iodine losses occur most likely due to the oxidation of folic acid by potassium iodate. Optimal salt formulations were prepared by spraying a pH 9 carbonate-bicarbonate buffer solution containing folic acid and iodine dissolved at 0.35% (w/v) each. Acceptable micronutrient retentions of > 90% were observed in refined salt after 6 months of storage at 45°C/60% relative humidity. Further investigations into increasing the concentration of iodine and folic acid in the spray solution are recommended.

Thesis (Ph.D.)--McMaster University, 2005. / Supervisor: G. J. Schrobilgen. Includes bibliographical references (leaves 305-318).